The Cannabis Alliance

As legislators sought perspectives on contemporary cannabis policy issues and regulators willingly shared, a group of publicly-funded prevention researchers kept their doors closed.

Licensees gave another round of feedback to agency staff engaged in rulemaking on how to set limits and requirements for cannabis product sampling by retail staff.

A mostly new team at the DOH Medical Cannabis Program solicited feedback on potential revisions to rules on compliant products, testing, labeling, and logos.

Following a march in Seattle, a legislative leader on cannabis shared how she became interested in sponsoring adult home growing legislation in Washington.

During the final webinar on 2024 draft request bills, WSLCB staff acknowledged one idea was likely to be shelved due to lack of support, but another would probably be moved forward.

WSLCB staff planned to accept comments on potential agency request legislation through the week which would end with a March for Homegrow in downtown Seattle.

WSLCB leaders introduced two concepts for 2024 request legislation, one for medical patients to contract with licensees; another to revise limits around cannabis retail advertising.

Reporting touched on why Licensing staff were “hands off” in the new phase of social equity applications, relocating producers over environmental pesticide concerns, and other updates.

Legislation expanding arrest projections for medical cannabis patients reflected the diligence of an advocate who had been pushing for various reforms on medical policies for several years.

The Governor approved a bill to allow interstate cannabis agreements if the practice became permitted by federal government action - and legislation had been introduced in Congress to do just that.